News

Dr. Sanders and Dr. Massey recap highlights from the American Association of Neuromuscular & Electrodiagnostic Medicine's 2024 conference.

Dr. Bedlack discusses how he helps his patients find hope in their ALS journeys while also making realistic plans for the future.

Richard Bedlack, MD, PhD has been named as the inaugural recipient of the Accelerate a Miracle Project (or AMP) Award by the Hop on a Cure Foundation. 

Read more about a study co-lead by Dr. Bedlack regarding ALS recovery.

Dr. Bedlack discusses ALSUntangled — a group dedicated to investigating alleged or emerging ALS treatments.

Dr. Bedlack comments on the use of Qalsody and its impact on ALS patients with the SOD1 gene.

Dr. Bedlack provides perspective on the results of the ALS drug trial for AMX005.

The final month of 2023 saw members of the Duke Neurology Department contributing to nine new peer-reviewed journal articles. Highlights include an analysis of symptoms associated with internal tremor for Parkinson’s disease, a trio of population-level studies for stroke, and a new examination of the connections between white matter and executive function. Read short summaries of each of these articles and find links to the original research below.

What do a speech prosthetic that translates brain signals into speech, retinal scans that detect cognitive impairment, and a promising new form of genetic therapy for Parkinson’s and some forms of dementia have in common? They’re all examples of the 21 peer-reviewed journal articles authored members of the Duke Neurology Department published this November.  

The month of September saw 20 new peer-reviewed journal articles articles and one book chapter from members of the Duke Neurology Department.